Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

France’s biotech sector continues to evolve, blending a strong academic foundation with a growing number of startups tackling diverse disease areas. While funding remains a significant hurdle, ...